Professional Summary
Professional Overview
Jess Schram is an accomplished investment and incubation professional with extensive experience in venture capital, strategic partnerships, and digital transformation. As the Director of Investments & Incubations at Remedy Product Studio, Jess is responsible for leading the firm's investment strategy, identifying promising startups, and driving the development of innovative new products and services. Additionally, Jess serves as a Venture Scout for leading venture capital firms, a Lead Mentor at Techstars, and an active investor and advisor.
Experience Summary
Current Roles
Director of Investments & Incubations, Remedy Product Studio (2023-09-01 to Present)
- Oversees the firm's investment strategy, portfolio management, and incubation initiatives
- Identifies and evaluates early-stage investment opportunities, providing strategic guidance and operational support to portfolio companies
- Collaborates with cross-functional teams to develop and launch new products and services that address emerging market needs
Venture Scout & LP, What If Ventures (2022-01-01 to Present)
- Sources and evaluates investment opportunities, conducting due diligence and providing insights to the investment team
- Actively engages with the firm's portfolio companies, offering strategic advice and operational support
Venture Scout, Headline (2023-08-01 to Present)
- Identifies and evaluates promising startups within Headline's target industries and investment themes
- Provides the investment team with market insights, competitive analysis, and recommendations
Lead Mentor, Techstars (2023-01-01 to Present)
- Mentors early-stage founders, guiding them through the challenges of building and scaling their businesses
- Leverages industry expertise to help startups refine their strategies, improve their operations, and secure funding
Career Progression
Prior to her current roles, Jess held various positions in the investment, business development, and digital transformation domains, including:
- Business Development & Strategic Partnerships, Journey Clinical (2023-03-01 to 2023-09-01)
- MBA Associate, Investment Team at 14W (2021-06-01 to 2022-03-01)
- Managing Director, Columbia Venture Fellows (2021-05-01 to 2022-05-01)
- Investor Relations, Office of the CEO at Elo Labs (2020-11-01 to 2021-05-01)
- Venture Scout, StartU (2020-10-01 to 2021-05-01)
- MBA Associate, Investment Team at Lerer Hippeau (2020-10-01 to 2021-06-01)
- Go to Market Strategy Consultant, Zero - Let's End Covid Together (2020-04-01 to 2020-08-01)
- Associate Director, Digital Transformation at Edelman (2019-09-01 to 2020-08-01)
Academic Background
Jess holds an MBA from a top-tier business school, where she specialized in finance and entrepreneurship. Her strong academic background, coupled with her diverse professional experiences, has equipped her with a unique blend of investment acumen, industry expertise, and strategic vision.
Areas of Expertise
- Venture capital and early-stage investing
- Startup incubation and acceleration
- Strategic partnerships and business development
- Digital transformation and innovation
- Mentoring and advising early-stage founders
Professional Impact
Throughout her career, Jess has made significant contributions to the startup ecosystem, leveraging her investment expertise and industry insights to identify and support promising emerging companies. Her work as a Venture Scout and Lead Mentor has helped numerous startups secure funding, refine their strategies, and scale their operations. Jess's commitment to innovation and her ability to navigate complex industry landscapes have firmly established her as a respected leader in the investment and incubation space.
Conclusion
With a proven track record of success in venture capital, strategic partnerships, and digital transformation, Jess Schram is poised to drive continued growth and impact in her role as the Director of Investments & Incubations at Remedy Product Studio. Her deep industry knowledge, strong investment acumen, and passion for mentoring and advising early-stage founders make her a valuable asset to any organization.